Big Pharma is in federal appeals court making the absurd argument that Medicare shouldn’t be able to negotiate drug prices, a power given it by the Inflation Reduction Act.
Something went wrong. Please refresh the page and/or try again.
Big Pharma is in federal appeals court making the absurd argument that Medicare shouldn’t be able to negotiate drug prices, a power given it by the Inflation Reduction Act.
Something went wrong. Please refresh the page and/or try again.
Sign up for the Washington Monthly newsletter to get our stories in your inbox. Opt out any time.